Article
Diagnosis, Classification and Management of Mast Cell Activation Syndromes (MCAS) in the Era of Personalized Medicine.
International journal of molecular sciences - 27 Nov 2020
Valent Peter, Akin Cem, Nedoszytko Boguslaw, Bonadonna Patrizia, Hartmann Karin, Niedoszytko Marek, Brockow Knut, Siebenhaar Frank, Triggiani Massimo, Arock Michel, Romantowski Jan, Górska Aleksandra, Schwartz Lawrence B, Metcalfe Dean D
Abstract excerpt
Mast cell activation (MCA) is seen in a variety of clinical contexts and pathologies, including IgE-dependent allergic inflammation, other immunologic and inflammatory reactions, primary mast cell (MC) disorders, and hereditary alpha tryptasemia (HAT). MCA-related symptoms range from mild to severe to life-threatening. The severity of MCA-related symptoms depends on a number of factors, including genetic...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.